Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can online therapy stop insulin resistance in HIV patients? new trial aims to find out

NCT ID NCT07226128

First seen Nov 10, 2025 · Last updated Jun 20, 2026 · Updated 30 times

Summary

This study tests whether an internet-based depression treatment called cognitive behavioral therapy (iCBT-D) can prevent insulin resistance from getting worse in adults with HIV who are on antiretroviral therapy and have depression. Researchers will compare the online therapy program to standard depression education in 150 participants over 12 months. The goal is to see if treating depression improves how the body uses insulin and reduces inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Indiana University Health

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

internet-based cognitive behavioral therapy (iCBT-D)

What this could lead to

If successful, this could show that treating depression with online therapy helps prevent insulin resistance and related health problems in people with HIV.

What could go wrong

This is a small, early-stage trial with only 150 participants, so results may not apply widely. The therapy may not improve insulin resistance as hoped.

Conditions

The condition(s) this trial relates to.

AIDS Depression depressive disorder diabetes mellitus HIV infectious disease Insulin Resistance major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.